載入...
Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
BACKGROUND: Tuberculosis (TB) is the world’s leading infectious cause of death. Extrapulmonary TB accounts for 15% of TB cases, but the proportion is increasing, and over half a million people were newly diagnosed with rifampicin‐resistant TB in 2016. Xpert(®) MTB/RIF (Xpert) is a World Health Organ...
Na minha lista:
| 發表在: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Ltd
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513199/ https://ncbi.nlm.nih.gov/pubmed/30148542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012768.pub2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|